Aquestive Therapeutics Inc
NASDAQ:AQST 4:00:00 PM EDT
| Market Cap (Intraday) | 621.79M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.82 |
| 50-Day MA | $4.15 |
| 200-Day MA | $3.39 |
Aquestive Therapeutics Inc Stock, NASDAQ:AQST
30 Technology Drive, Warren, New Jersey 07059
United States of America
Phone: +1.908.941.1900
Number of Employees: 142
Description
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients� therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.